GoHealth Inc (GOCO) vs. Its Peers: A Comparison

VLD Stock

Additionally, the 36-month beta value for GOCO is 1.48. There are mixed opinions on the stock, with 4 analysts rating it as a “buy”, 0 rating it as “overweight”, 1 rating it as “hold”, and 0 rating it as “sell”.

The public float for GOCO is 8.53M and currently, short sellers hold a 1.19% ratio of that float. The average trading volume of GOCO on July 04, 2025 was 68.56K shares.

GOCO stock’s latest price update

The stock price of GoHealth Inc (NASDAQ: GOCO) has jumped by 1.19% compared to previous close of $5.86. Despite this, the company has seen a fall of -0.34% in its stock price over the last five trading days. prnewswire.com reported 2025-07-03 that NEW YORK, July 3, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public. So What: If you purchased GoHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

GOCO’s Market Performance

GOCO’s stock has fallen by -0.34% in the past week, with a monthly drop of -0.34% and a quarterly drop of -50.29%. The volatility ratio for the week is 7.77% while the volatility levels for the last 30 days are 8.47% for GoHealth Inc The simple moving average for the past 20 days is 2.84% for GOCO’s stock, with a -47.43% simple moving average for the past 200 days.

Analysts’ Opinion of GOCO

Many brokerage firms have already submitted their reports for GOCO stocks, with Credit Suisse repeating the rating for GOCO by listing it as a “Underperform”. The predicted price for GOCO in the upcoming period, according to Credit Suisse is $1.50 based on the research report published on April 01, 2022 of the previous year 2022.

RBC Capital Mkts, on the other hand, stated in their research note that they expect to see GOCO reach a price target of $2, previously predicting the price at $10. The rating they have provided for GOCO stocks is “Sector Perform” according to the report published on March 03rd, 2022.

Credit Suisse gave a rating of “Underperform” to GOCO, setting the target price at $3 in the report published on January 07th of the previous year.

GOCO Trading at -14.33% from the 50-Day Moving Average

After a stumble in the market that brought GOCO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -71.76% of loss for the given period.

Volatility was left at 8.47%, however, over the last 30 days, the volatility rate increased by 7.77%, as shares surge +1.19% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -45.40% lower at present.

During the last 5 trading sessions, GOCO fell by -0.34%, which changed the moving average for the period of 200-days by -32.84% in comparison to the 20-day moving average, which settled at $5.77. In addition, GoHealth Inc saw -43.20% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

N/A, the N/A of GoHealth Inc, N/A N/A shares at N/A during a trade that took place back on N/A, which means that N/A is holding N/A shares at N/A based on the most recent closing price.

Stock Fundamentals for GOCO

Current profitability levels for the company are sitting at:

  • 0.0% for the present operating margin
  • 0.85% for the gross margin

The net margin for GoHealth Inc stands at -0.0%. The total capital return value is set at 0.0%. Equity return is now at value 0.80%, with 0.14% for asset returns.

Based on GoHealth Inc (GOCO), the company’s capital structure generated 0.24 points at debt to capital in total, while cash flow to debt ratio is standing at -0.72. The debt to equity ratio resting at 0.32. The interest coverage ratio of the stock is 0.05.

Currently, EBITDA for the company is 101.32 million with net debt to EBITDA at 0.34. When we switch over and look at the enterprise to sales, we see a ratio of 0.14. The receivables turnover for the company is 0.83for trailing twelve months and the total asset turnover is 0.6. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.12.

Conclusion

In conclusion, GoHealth Inc (GOCO) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts

favicon-nh
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.